Hantavirus Death Rate by Age

CDC publishes a single fatality rate for hantavirus pulmonary syndrome — about 38% once respiratory symptoms develop — and no breakdown by age at all. The peer-reviewed surveillance literature does have one, and its answer is not the one most people expect: age barely moves the chance of dying. It strongly changes how fast death comes.

Last reviewed: November 2, 2026  |  Sources: Thorp et al., Pediatrics 2023 (n=719); MacNeil et al., Emerg Infect Dis 2011 (n=510); Jackson et al., Am J Trop Med Hyg 2025 (California, n=89); CDC surveillance data

The Short Answer

Mortality did not differ by age group. In the largest study of US hantavirus pulmonary syndrome ever assembled — 719 patients reported nationally from 1993 to 2018 — overall mortality was 35.4%, and the difference between children (0–12), adolescents (13–18) and adults was not statistically significant (P = 0.8). Time from symptom onset to death did differ, and sharply: a median of 2 days in children, 4 in adolescents, 5 in adults (P = 0.001). Source: Thorp L, Fullerton L, Whitesell A, Dehority W. Pediatrics 2023;151(4):e2022059352.

That study — authored with CDC's Viral Special Pathogens Branch and drawing on CDC's national database plus one state health department, covering 97% of US cases — is the only published analysis large enough to compare outcomes across age groups. Its finding is worth stating plainly because it inverts the usual pattern for severe respiratory illness, where the very young and the very old fare worst. For HPS, on the evidence available, your age does not predict whether you survive; it predicts how much time anyone has to act.

Thorp L, Fullerton L, Whitesell A, Dehority W. Hantavirus Pulmonary Syndrome: 1993–2018. Pediatrics 2023;151(4):e2022059352. doi:10.1542/peds.2022-059352. Age groups are the study's own. IQR = interquartile range. The study reports that mortality did not differ significantly between the three groups (P = 0.8) and that time from onset to death did (P = 0.001); it does not publish a separate percentage fatality figure for each group, so none is invented here.
Age groupPatientsShare of casesMedian days from symptom onset to death
Children, 0–12 years223.0%2 days (IQR 2–3)
Adolescents, 13–18 years476.5%4 days (IQR 3–5)
Adults, 19+ years65090.4%5 days (IQR 4–8)
All ages719100%Overall mortality 35.4%, no significant difference by age (P = 0.8)

The authors' own conclusion: in "the largest study of HPS in the United States," they "found that children with HPS died more quickly than adults and that highest hematocrit and creatinine levels were associated with death only among those <19 years old." Two laboratory values that flag a deteriorating child, in other words, do not flag a deteriorating adult — and the child has roughly half the time.

Why Hantavirus Looks Like an Adult Disease

Ninety percent of US HPS patients are adults, and it is easy to read that as an age-related vulnerability. It is not. It is a map of who does the work that creates exposure.

Hantavirus is acquired by inhaling virus aerosolised from the urine, droppings or nesting material of infected rodents — in the United States, chiefly the deer mouse (Peromyscus maniculatus) carrying Sin Nombre virus. The activities that aerosolise it are sweeping a shed, opening a cabin after winter, clearing a crawlspace, moving stored boxes, working in a barn. Those are adult activities. California's review of all 89 cases in state residents from 1993 to 2020 found a mean patient age of 41.5 years, 63% male, with indoor and peridomestic exposure more common than worksite or recreational exposure, and visual evidence of rodent activity in 74% of the 70 environmental investigations conducted (Jackson et al., Am J Trop Med Hyg 2025;113(6):1385–92).

So the age distribution is an exposure distribution. A child who does aerosolise infected rodent material appears to face the same odds as an adult who does — with less time before the odds resolve. Our transmission page covers the exposure routes in full, and the prevention guide gives CDC's cleanup protocol, including the reason never to dry-sweep or vacuum.

Every Published US Fatality Rate, and Why They Differ

Sources as cited in the reference list below. All figures are case-fatality rates among reported, laboratory-confirmed cases — never a per-exposure risk. Percentages marked "our calculation" are arithmetic on the source's own published counts.
SourcePeriod & populationCasesDeathsCFR
CDC headline figureHPS, once respiratory symptoms develop——≈38%
CDC cumulative case fileUS, 1993–2023, all reported hantavirus disease (859 HPS + 31 non-pulmonary)89030934.7% (our calculation)
MacNeil et al., EID 2011US HPS registry, 1993–2009510—35%
Thorp et al., Pediatrics 2023US national dataset, 1993–2018 (97% of cases)719—35.4%
Jackson et al., AJTMH 2025California residents, 1993–2020892831%
PAHO regional alertThe Americas, 2025 to week 47 (8 countries)2295925.7%
Three reasons the numbers move: which cases count (CDC's cumulative file includes the milder non-pulmonary category, recorded only since 2015, which pulls the rate below the HPS-only figure); which years (case counts have run from 11 to 48 a year with no trend in either direction, so short windows are noisy); and which country (South American outbreaks involve Andes virus, a different hantavirus with person-to-person transmission documented in Argentina — a materially different disease).

The consistency across the US series is the more useful fact. Four independent datasets spanning three decades land between 31% and 38%. Whatever else is uncertain about hantavirus, the lethality of the pulmonary syndrome is a stable, well-replicated number — and it has not fallen, because there is still no antiviral and no vaccine licensed in the Americas. Our treatment page sets out what supportive care can and cannot do.

What Is Not Published — Stated Plainly

  • No official CFR by age band. CDC's public surveillance pages give a cumulative case count, a state map and a single fatality figure. No age-stratified fatality table exists in CDC's published output, which is why this page is built on the peer-reviewed series instead (checked September 19, 2026).
  • No per-group percentage in the one study that compared groups. Thorp et al. report that mortality did not differ significantly by age and give the overall 35.4%; they do not publish a fatality percentage for each of the three groups. We do not compute one from the group sizes, because the deaths are not reported per group — the arithmetic would be invention.
  • No elderly-specific analysis. "Adults" in the national dataset is a single group from 19 upward. Whether a 75-year-old with HPS fares differently from a 30-year-old is, on the published evidence, unknown.
  • No hospitalisation or severe-outcome rate. CDC publishes neither for hantavirus, at any age. Those cells are left blank on our risk perspective page rather than filled with an estimate.
  • Recent counts are provisional. CDC has finalised no annual figure after 2023, and its year-end provisional counts for 2022, 2023 and 2024 were each revised upward by a third or more. Any single recent year's fatality ratio is unstable by construction; see outbreaks and surveillance.

This page reports published surveillance statistics and is educational information, not medical advice or a risk assessment for any individual. If you or a family member has flu-like symptoms after cleaning a rodent-infested space, contact a clinician and say so explicitly — the median time from symptom onset to death in the data above is measured in days, and early escalation of care is the only lever that exists.

Frequently Asked Questions

What is the hantavirus death rate by age?

CDC publishes no age breakdown. The largest US study — 719 HPS patients, 1993–2018 — found overall mortality of 35.4% with no significant difference between children, adolescents and adults (P = 0.8). Time from symptom onset to death did differ: 2 days in children, 4 in adolescents, 5 in adults (P = 0.001). Age changes the speed, not the odds.

Are children more likely to die from hantavirus than adults?

Not on the available evidence — mortality did not differ significantly by age group in the national dataset. Children did die faster (median 2 days versus 5), and in that study high hematocrit and creatinine predicted death in under-19s but not in adults. Children are also rare among cases: 22 of 719 patients were 12 or younger.

What age group gets hantavirus most often?

Working-age adults — 650 of 719 patients (90.4%) in the national dataset; mean age 41.5 years and 63% male in California's 89 cases. That is an exposure pattern, not a susceptibility pattern: cleaning sheds, crawlspaces and cabins is mostly done by adults.

Why is the fatality rate 38% in some sources and 35% in others?

Different denominators. CDC's ≈38% is HPS once respiratory symptoms develop. CDC's cumulative file gives 309 deaths in 890 cases (34.7%), including 31 milder non-pulmonary infections counted only since 2015. The peer-reviewed series give 35% (n=510), 35.4% (n=719) and 31% (California, n=89). All are case-fatality rates among diagnosed cases, never a per-exposure risk.

Does age affect how quickly hantavirus symptoms progress?

In the one study that measured it, yes — markedly. Median time from symptom onset to death was 2 days for children, 4 for adolescents and 5 for adults. HPS in any patient begins with 1–8 weeks of non-specific flu-like illness and can then progress to fluid in the lungs and cardiogenic shock within 4–10 days, per CDC. The pediatric finding compresses that window further, which is the practical reason to name the rodent exposure to a clinician rather than wait.

Sources & References

  1. Thorp L, Fullerton L, Whitesell A, Dehority W. Hantavirus Pulmonary Syndrome: 1993–2018. Pediatrics 2023;151(4):e2022059352. doi:10.1542/peds.2022-059352 · PMID 36855865
  2. MacNeil A, Ksiazek TG, Rollin PE. Hantavirus pulmonary syndrome, United States, 1993–2009. Emerg Infect Dis 2011;17(7):1195–201. doi:10.3201/eid1707.101306
  3. Knust B, Rollin PE. Twenty-year summary of surveillance for human hantavirus infections, United States. Emerg Infect Dis 2013;19(12):1934–7. doi:10.3201/eid1912.131217
  4. Jackson BT, Kjemtrup AM, Novak MG, et al. Epidemiologic and environmental investigations of reported hantavirus cases inform exposure risk in California, 1993–2020. Am J Trop Med Hyg 2025;113(6):1385–92. doi:10.4269/ajtmh.25-0270
  5. Centers for Disease Control and Prevention. Reported Cases of Hantavirus Disease (page dated April 23, 2026) and its underlying patient-level case file — source of the 890 cases / 309 deaths cumulative figures for 1993–2023. cdc.gov/hantavirus/data-research/cases
  6. Centers for Disease Control and Prevention. About Hantavirus — HPS symptoms start 1 to 8 weeks after contact; late (cardiopulmonary) symptoms 4 to 10 days after the initial phase; no specific treatment, supportive care. cdc.gov/hantavirus/about
  7. Centers for Disease Control and Prevention. NNDSS Weekly Data, dataset x9gk-5huc — provisional annual HPS counts and their upward revisions. data.cdc.gov/NNDSS/NNDSS-Weekly-Data/x9gk-5huc
  8. Pan American Health Organization / WHO. Epidemiological Alert: Hantavirus Pulmonary Syndrome in the Americas Region, 19 December 2025 — regional 2025 counts through epidemiological week 47. paho.org
  9. Martinez VP, et al. "Super-spreaders" and person-to-person transmission of Andes virus in Argentina. N Engl J Med 2020;383:2230–41. doi:10.1056/NEJMoa2009040